This occurs through downstream activation of mTORC1 by PI3K/Akt, which upregulates glucose transporter expression and glycolytic enzymes like hexokinase II, promoting anabolic metabolism and tumor cell survival. The gene discussed is AKT1; the disease is neoplasm.